+1 (704) 266-3234

Measles Vaccine Market Europe Outlook Report 2017

Published on: Apr 2017 | From USD $3922 | Published By: QY RESEARCH | Number Of Pages: 137


This report studies the Measles Vaccine market status and outlook of Europe and major countries, from angles of players, countries, product types and end industries; this report analyzes the top players in Europe and major countries, and splits the Measles Vaccine market by product type and applications/end industries.

The global Measles Vaccine market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Europe also play important roles in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of XX.
The major players in Europe market include Bavarian Nordic, Emergent Biosolutions, GlaxoSmithKline, Medimmune, Johnson & Johnson, CSL Limited, Merck & Co., Novartis AG, Pfizer, Sanofi
Figures Global and Europe Market Size (Million USD) Comparison 2012-2022
Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Measles Vaccine in these regions, from 2012 to 2022 (forecast), covering
Germany
UK
France
Russia
Benelux
Italy
Spain

On the basis of product, the Measles Vaccine market is primarily split into

MMR-II
Proquad

On the basis on the end users/applications, this report covers

Pediatric Vaccines
Adult Vaccines
-



Table of Contents

Europe Measles Vaccine Industry 2017 Market Research Report
1 Measles Vaccine Overview
1.1 Product Overview and Scope of Measles Vaccine
1.2 Classification of Measles Vaccine by Product Category
1.2.1 Europe Measles Vaccine Sales (K Sets) Comparison by Types (2012-2022)
1.2.2 Europe Measles Vaccine Sales (K Sets) Market Share (%) by Types (Product Category) in 2016
1.2.3 MMR-II
1.2.4 Proquad
1.3 Europe Measles Vaccine Market by Applications/End Users
1.3.1 Europe Measles Vaccine Sales (K Sets) and Market Share (%) Comparison by Applications (2012-2022)
1.3.2 Pediatric Vaccines
1.3.3 Adult Vaccines
1.4 Europe Measles Vaccine Market by Countries
1.4.1 Europe Measles Vaccine Revenue (Million USD) Comparison by Countries (2012-2022)
1.4.2 Germany Measles Vaccine Status and Prospect (2012-2022)
1.4.3 France Measles Vaccine Status and Prospect (2012-2022)
1.4.4 UK Measles Vaccine Status and Prospect (2012-2022)
1.4.5 Russia Measles Vaccine Status and Prospect (2012-2022)
1.4.6 Italy Measles Vaccine Status and Prospect (2012-2022)
1.4.7 Benelux Measles Vaccine Status and Prospect (2012-2022)
1.4.8 Spain Measles Vaccine Status and Prospect (2012-2022)
1.5 Europe Market Size (Revenue and Sales) of Measles Vaccine (2012-2022)
1.5.1 Europe Measles Vaccine Sales (K Sets) and Growth Rate (%) (2012-2022)
1.5.2 Europe Measles Vaccine Revenue (Million USD) and Growth Rate (%) (2012-2022)
2 Europe Measles Vaccine by Players, Type and Application
2.1 Europe Measles Vaccine Market Competition by Players/Suppliers
2.1.1 Europe Measles Vaccine Sales (K Sets) and Market Share (%) of Key Players (2012-2017)
2.1.2 Europe Measles Vaccine Revenue (Million USD) and Share (%) by Players (2012-2017)
2.2 Europe Measles Vaccine (Revenue and Sales) by Type
2.2.1 Europe Measles Vaccine Sales (K Sets) and Market Share (%) by Type (2012-2017)
2.2.2 Europe Measles Vaccine Revenue and Market Share (%) by Type (2012-2017)
2.3 Europe Measles Vaccine (Revenue and Sales) by Countries
2.3.1 Europe Measles Vaccine Sales (K Sets) and Market Share (%) by Countries (2012-2017)
2.3.2 Europe Measles Vaccine Revenue and Market Share (%) by Countries (2012-2017)
2.4 Europe Measles Vaccine Sales (K Sets) by Application
3 Germany Measles Vaccine (Revenue, Sales and Price)
3.1 Germany Measles Vaccine (Revenue and Sales) (2012-2017)
3.1.1 Germany Measles Vaccine Sales (K Sets) and Growth Rate (%) (2012-2017)
3.1.2 Germany Measles Vaccine Revenue (Million USD) and Growth Rate (%) (2012-2017)
3.1.3 Germany Measles Vaccine Sales Price Trend (2012-2017)
3.2 Germany Measles Vaccine Sales (K Sets) and Market Share (%) by Players/Supplier
3.3 Germany Measles Vaccine Sales (K Sets) and Market Share (%) by Type
3.4 Germany Measles Vaccine Sales (K Sets) and Market Share (%) by Applications
4 UK Measles Vaccine (Revenue, Sales and Price)
4.1 UK Measles Vaccine (Revenue and Sales) (2012-2017)
4.1.1 UK Measles Vaccine Sales (K Sets) and Growth Rate (%) (2012-2017)
4.1.2 UK Measles Vaccine Revenue (Million USD) and Growth Rate (%) (2012-2017)
4.1.3 UK Measles Vaccine Sales Price Trend (2012-2017)
4.2 UK Measles Vaccine Sales (K Sets) and Market Share (%) by Players/Supplier
4.3 UK Measles Vaccine Sales (K Sets) and Market Share (%) by Type
4.4 UK Measles Vaccine Sales (K Sets) and Market Share (%) by Applications
5 France Measles Vaccine (Revenue, Sales and Price)
5.1 France Measles Vaccine (Revenue and Sales) (2012-2017)
5.1.1 France Measles Vaccine Sales (K Sets) and Growth Rate (%) (2012-2017)
5.1.2 France Measles Vaccine Revenue (Million USD) and Growth Rate (%) (2012-2017)
5.1.3 France Measles Vaccine Sales Price Trend (2012-2017)
5.2 France Measles Vaccine Sales (K Sets) and Market Share (%) by Players/Supplier
5.3 France Measles Vaccine Sales (K Sets) and Market Share (%) by Type
5.4 France Measles Vaccine Sales (K Sets) and Market Share (%) by Applications
6 Russia Measles Vaccine (Revenue, Sales and Price)
6.1 Russia Measles Vaccine (Revenue and Sales) (2012-2017)
6.1.1 Russia Measles Vaccine Sales (K Sets) and Growth Rate (%) (2012-2017)
6.1.2 Russia Measles Vaccine Revenue (Million USD) and Growth Rate (%) (2012-2017)
6.1.3 Russia Measles Vaccine Sales Price Trend (2012-2017)
6.2 Russia Measles Vaccine Sales (K Sets) and Market Share (%) by Players/Supplier
6.3 Russia Measles Vaccine Sales (K Sets) and Market Share (%) by Type
6.4 Russia Measles Vaccine Sales (K Sets) and Market Share (%) by Applications
7 Benelux Measles Vaccine (Revenue, Sales and Price)
7.1 Benelux Measles Vaccine (Revenue and Sales) (2012-2017)
7.1.1 Benelux Measles Vaccine Sales (K Sets) and Growth Rate (%) (2012-2017)
7.1.2 Benelux Measles Vaccine Revenue (Million USD) and Growth Rate (%) (2012-2017)
7.1.3 Benelux Measles Vaccine Sales Price Trend (2012-2017)
7.2 Benelux Measles Vaccine Sales (K Sets) and Market Share (%) by Players/Supplier
7.3 Benelux Measles Vaccine Sales (K Sets) and Market Share (%) by Type
7.4 Benelux Measles Vaccine Sales (K Sets) and Market Share (%) by Applications
8 Italy Measles Vaccine (Revenue, Sales and Price)
8.1 Italy Measles Vaccine (Revenue and Sales) (2012-2017)
8.1.1 Italy Measles Vaccine Sales (K Sets) and Growth Rate (%) (2012-2017)
8.1.2 Italy Measles Vaccine Revenue (Million USD) and Growth Rate (%) (2012-2017)
8.1.3 Italy Measles Vaccine Sales Price Trend (2012-2017)
8.2 Italy Measles Vaccine Sales (K Sets) and Market Share (%) by Players
8.3 Italy Measles Vaccine Sales (K Sets) and Market Share (%) by Type
8.4 Italy Measles Vaccine Sales (K Sets) and Market Share (%) by Applications
9 Spain Measles Vaccine (Revenue, Sales and Price)
9.1 Spain Measles Vaccine (Revenue and Sales) (2012-2017)
9.1.1 Spain Measles Vaccine Sales (K Sets) and Growth Rate (%) (2012-2017)
9.1.2 Spain Measles Vaccine Revenue (Million USD) and Growth Rate (%) (2012-2017)
9.1.3 Spain Measles Vaccine Sales Price Trend (2012-2017)
9.2 Spain Measles Vaccine Sales (K Sets) and Market Share (%) by Players
9.3 Spain Measles Vaccine Sales (K Sets) and Market Share (%) by Type
9.4 Spain Measles Vaccine Sales (K Sets) and Market Share (%) by Applications
10 Europe Measles Vaccine Players/Suppliers Profiles and Sales Data
10.1 Bavarian Nordic
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Measles Vaccine Product Types, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Bavarian Nordic Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Emergent Biosolutions
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Measles Vaccine Product Types, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Emergent Biosolutions Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
10.2.4 Main Business/Business Overview
10.3 GlaxoSmithKline
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Measles Vaccine Product Types, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 GlaxoSmithKline Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Medimmune
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Measles Vaccine Product Types, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Medimmune Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Johnson & Johnson
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Measles Vaccine Product Types, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Johnson & Johnson Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
10.5.4 Main Business/Business Overview
10.6 CSL Limited
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Measles Vaccine Product Types, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 CSL Limited Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
10.6.4 Main Business/Business Overview
10.7 Merck & Co.
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Measles Vaccine Product Types, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 Merck & Co. Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
10.7.4 Main Business/Business Overview
10.8 Novartis AG
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Measles Vaccine Product Types, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 Novartis AG Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
10.8.4 Main Business/Business Overview
10.9 Pfizer
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Measles Vaccine Product Types, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 Pfizer Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
10.9.4 Main Business/Business Overview
10.10 Sanofi
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Measles Vaccine Product Types, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 Sanofi Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
10.10.4 Main Business/Business Overview
11 Measles Vaccine Manufacturing Cost Analysis
11.1 Measles Vaccine Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Measles Vaccine
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Measles Vaccine Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Measles Vaccine Major Players in 2016
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Europe Measles Vaccine Market Size (Revenue and Sales) Forecast (2017-2022)
14.1 Germany Measles Vaccine Sales (K Sets) Forecast (2017-2022)
14.2 UK Measles Vaccine Sales (K Sets) Forecast (2017-2022)
14.3 France Measles Vaccine Sales (K Sets) Forecast (2017-2022)
14.4 Russia Measles Vaccine Sales (K Sets) Forecast (2017-2022)
14.5 Benelux Measles Vaccine Sales (K Sets) Forecast (2017-2022)
14.6 Italy Measles Vaccine Sales (K Sets) Forecast (2017-2022)
14.7 Spain Measles Vaccine Sales (K Sets) Forecast (2017-2022)
14.8 Europe Measles Vaccine Sales (K Sets) Forecast by Countries (2017-2022)
14.9 Europe Measles Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
14.10 Europe Measles Vaccine (K Sets) Sales Forecast by Type (2017-2022)
14.11 Europe Measles Vaccine (K Sets) Sales Forecast by Applications (2017-2022)
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
16.4 Author List

List of Tables and Figures

Figures Global and Europe Market Size (Million USD) Comparison 2012-2022
Table Europe Market Measles Vaccine Revenue (Million USD) Comparison by Regions 2012-2022
Table Europe Measles Vaccine Sales (K Sets) and Revenue (Million USD) Market Split by Product Type
Table Europe Measles Vaccine Sales (K Sets) by Application (2016-2022)
Figure Product Picture of Measles Vaccine
Table Europe Measles Vaccine Sales (K Sets) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure Europe Measles Vaccine Sales (K Sets) Market Share (%) by Types (Product Category) in 2016
Figure MMR-II Product Picture
Figure Proquad Product Picture
Table Europe Measles Vaccine Sales (K Sets) Comparison by Applications (2012-2022)
Figure Europe Sales Market Share (%) of Measles Vaccine by Applications in 2016
Figure Pediatric Vaccines Examples
Figure Adult Vaccines Examples
Table Europe Market Measles Vaccine Revenue (Million USD) Comparison by Regions 2012-2022
Figure Europe Measles Vaccine Revenue (Million USD) Comparison by Countries (2012-2022)
Figure Germany Measles Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure France Measles Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure UK Measles Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Russia Measles Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Italy Measles Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Benelux Measles Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Spain Measles Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Measles Vaccine Sales (K Sets) and Growth Rate (%) (2012-2022)
Figure Europe Measles Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Table Europe Measles Vaccine Sales of Key Players (2012-2017)
Table Europe Measles Vaccine Sales Share (%) by Players (2012-2017)
Figure 2015 Europe Measles Vaccine Sales Share (%) by Players
Figure 2016 Europe Measles Vaccine Sales Share (%) by Players
Table Europe Measles Vaccine Revenue (Million USD) by Players (2012-2017)
Table Europe Measles Vaccine Revenue Share (%) by Players (2012-2017)
Figure 2016 Europe Measles Vaccine Revenue Share (%) by Players
Figure 2017 Europe Measles Vaccine Revenue Share (%) by Players
Table Europe Measles Vaccine Sales (K Sets) and Market Share (%) by Type (2012-2017)
Table Europe Measles Vaccine Sales Share (%) by Type (2012-2017)
Figure Sales Market Share (%) of Measles Vaccine by Type (2012-2017)
Figure Europe Measles Vaccine Sales (K Sets) and Growth Rate (%) by Type (2012-2017)
Table Europe Measles Vaccine Revenue (Million USD) and Market Share (%) by Type (2012-2017)
Table Europe Measles Vaccine Revenue Share (%) by Type (2012-2017)
Figure Revenue Market Share (%) of Measles Vaccine by Type (2012-2017)
Figure Europe Measles Vaccine Revenue Growth Rate by Type (2012-2017)
Table Europe Measles Vaccine Sales (K Sets) and Market Share (%) by Countries (2012-2017)
Table Europe Measles Vaccine Sales Share (%) by Countries (2012-2017)
Figure Sales Market Share (%) of Measles Vaccine by Countries (2012-2017)
Figure Sales Market Share (%) of Measles Vaccine by Countries in 2016
Table Europe Measles Vaccine Revenue (Million USD) and Market Share (%) by Countries (2012-2017)
Table Europe Measles Vaccine Revenue Share (%) by Countries (2012-2017)
Figure Revenue Market Share (%) of Measles Vaccine by Countries (2012-2017)
Figure Revenue Market Share (%) of Measles Vaccine by Countries in 2016
Table Europe Measles Vaccine Sales (K Sets) and Market Share (%) by Application (2012-2017)
Figure Europe Measles Vaccine Sales Share (%) by Application (2012-2017)
Figure Sales Market Share (%) of Measles Vaccine by Application (2012-2017)
Figure Sales Market Share (%) of Measles Vaccine by Application in 2016
Figure Germany Measles Vaccine Sales (K Sets) and Growth Rate (%) (2012-2017)
Figure Germany Measles Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Germany Measles Vaccine Sales Price Trend (2012-2017)
Table Germany Measles Vaccine Sales by Players (2012-2017)
Table Germany Measles Vaccine Sales Market Share (%) by Players (2012-2017)
Figure Germany Measles Vaccine Sales Market Share (%) by Players in 2016
Table Germany Measles Vaccine Sales by Type (2012-2017)
Table Germany Measles Vaccine Sales Market Share (%) by Type (2012-2017)
Figure Germany Measles Vaccine Sales Market Share (%) by Type in 2016
Table Germany Measles Vaccine Sales by Applications (2012-2017)
Table Germany Measles Vaccine Sales Market Share (%) by Applications (2012-2017)
Figure Germany Measles Vaccine Sales Market Share (%) by Applications in 2016
Figure UK Measles Vaccine Sales (K Sets) and Growth Rate (%) (2012-2017)
Figure UK Measles Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Figure UK Measles Vaccine Sales Price Trend (2012-2017)
Table UK Measles Vaccine Sales by Players (2012-2017)
Table UK Measles Vaccine Sales Market Share (%) by Players (2012-2017)
Figure UK Measles Vaccine Sales Market Share (%) by Players in 2016
Table UK Measles Vaccine Sales by Type (2012-2017)
Table UK Measles Vaccine Sales Market Share (%) by Type (2012-2017)
Figure UK Measles Vaccine Sales Market Share (%) by Type in 2016
Table UK Measles Vaccine Sales by Applications (2012-2017)
Table UK Measles Vaccine Sales Market Share (%) by Applications (2012-2017)
Figure UK Measles Vaccine Sales Market Share (%) by Applications in 2016
Figure France Measles Vaccine Sales (K Sets) and Growth Rate (%) (2012-2017)
Figure France Measles Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Figure France Measles Vaccine Sales Price Trend (2012-2017)
Table France Measles Vaccine Sales by Players (2012-2017)
Table France Measles Vaccine Sales Market Share (%) by Players (2012-2017)
Figure France Measles Vaccine Sales Market Share (%) by Players in 2016
Table France Measles Vaccine Sales by Type (2012-2017)
Table France Measles Vaccine Sales Market Share (%) by Type (2012-2017)
Figure France Measles Vaccine Sales Market Share (%) by Type in 2016
Table France Measles Vaccine Sales by Applications (2012-2017)
Table France Measles Vaccine Sales Market Share (%) by Applications (2012-2017)
Figure France Measles Vaccine Sales Market Share (%) by Applications in 2016
Figure Russia Measles Vaccine Sales (K Sets) and Growth Rate (%) (2012-2017)
Figure Russia Measles Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Russia Measles Vaccine Sales Price Trend (2012-2017)
Table Russia Measles Vaccine Sales by Players (2012-2017)
Table Russia Measles Vaccine Sales Market Share (%) by Players (2012-2017)
Figure Russia Measles Vaccine Sales Market Share (%) by Players in 2016
Table Russia Measles Vaccine Sales by Type (2012-2017)
Table Russia Measles Vaccine Sales Market Share (%) by Type (2012-2017)
Figure Russia Measles Vaccine Sales Market Share (%) by Type in 2016
Table Russia Measles Vaccine Sales by Applications (2012-2017)
Table Russia Measles Vaccine Sales Market Share (%) by Applications (2012-2017)
Figure Russia Measles Vaccine Sales Market Share (%) by Applications in 2016
Figure Benelux Measles Vaccine Sales (K Sets) and Growth Rate (%) (2012-2017)
Figure Benelux Measles Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Benelux Measles Vaccine Sales Price Trend (2012-2017)
Table Benelux Measles Vaccine Sales by Players (2012-2017)
Table Benelux Measles Vaccine Sales Market Share (%) by Players (2012-2017)
Figure Benelux Measles Vaccine Sales Market Share (%) by Players in 2016
Table Benelux Measles Vaccine Sales by Type (2012-2017)
Table Benelux Measles Vaccine Sales Market Share (%) by Type (2012-2017)
Figure Benelux Measles Vaccine Sales Market Share (%) by Type in 2016
Table Benelux Measles Vaccine Sales by Applications (2012-2017)
Table Benelux Measles Vaccine Sales Market Share (%) by Applications (2012-2017)
Figure Benelux Measles Vaccine Sales Market Share (%) by Benelux in 2016
Figure Italy Measles Vaccine Sales (K Sets) and Growth Rate (%) (2012-2017)
Figure Italy Measles Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Italy Measles Vaccine Sales Price Trend (2012-2017)
Table Italy Measles Vaccine Sales by Players (2012-2017)
Table Italy Measles Vaccine Sales Market Share (%) by Players (2012-2017)
Figure Italy Measles Vaccine Sales Market Share (%) by Players in 2016
Table Italy Measles Vaccine Sales by Type (2012-2017)
Table Italy Measles Vaccine Sales Market Share (%) by Type (2012-2017)
Figure Italy Measles Vaccine Sales Market Share (%) by Type in 2016
Table Italy Measles Vaccine Sales by Applications (2012-2017)
Table Italy Measles Vaccine Sales Market Share (%) by Applications (2012-2017)
Figure Italy Measles Vaccine Sales Market Share (%) by Applications in 2016
Figure Spain Measles Vaccine Sales (K Sets) and Growth Rate (%) (2012-2017)
Figure Spain Measles Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Spain Measles Vaccine Sales Price Trend (2012-2017)
Table Spain Measles Vaccine Sales by Players (2012-2017)
Table Spain Measles Vaccine Sales Market Share (%) by Players (2012-2017)
Figure Spain Measles Vaccine Sales Market Share (%) by Players in 2016
Table Spain Measles Vaccine Sales by Type (2012-2017)
Table Spain Measles Vaccine Sales Market Share (%) by Type (2012-2017)
Figure Spain Measles Vaccine Sales Market Share (%) by Type in 2016
Table Spain Measles Vaccine Sales by Applications (2012-2017)
Table Spain Measles Vaccine Sales Market Share (%) by Applications (2012-2017)
Figure Spain Measles Vaccine Sales Market Share (%) by Applications in 2016
Table Bavarian Nordic Basic Information List
Table Bavarian Nordic Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
Figure Bavarian Nordic Measles Vaccine Sales (K Sets) and Growth Rate (%) (2012-2017)
Figure Bavarian Nordic Measles Vaccine Sales Market Share (%) in Europe (2012-2017)
Figure Bavarian Nordic Measles Vaccine Revenue Market Share (%) in Europe (2012-2017)
Table Emergent Biosolutions Basic Information List
Table Emergent Biosolutions Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
Figure Emergent Biosolutions Measles Vaccine Sales (K Sets) and Growth Rate (%) (2012-2017)
Figure Emergent Biosolutions Measles Vaccine Sales Market Share (%) in Europe (2012-2017)
Figure Emergent Biosolutions Measles Vaccine Revenue Market Share (%) in Europe (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
Figure GlaxoSmithKline Measles Vaccine Sales (K Sets) and Growth Rate (%) (2012-2017)
Figure GlaxoSmithKline Measles Vaccine Sales Market Share (%) in Europe (2012-2017)
Figure GlaxoSmithKline Measles Vaccine Revenue Market Share (%) in Europe (2012-2017)
Table Medimmune Basic Information List
Table Medimmune Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
Figure Medimmune Measles Vaccine Sales (K Sets) and Growth Rate (%) (2012-2017)
Figure Medimmune Measles Vaccine Sales Market Share (%) in Europe (2012-2017)
Figure Medimmune Measles Vaccine Revenue Market Share (%) in Europe (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
Figure Johnson & Johnson Measles Vaccine Sales (K Sets) and Growth Rate (%) (2012-2017)
Figure Johnson & Johnson Measles Vaccine Sales Market Share (%) in Europe (2012-2017)
Figure Johnson & Johnson Measles Vaccine Revenue Market Share (%) in Europe (2012-2017)
Table CSL Limited Basic Information List
Table CSL Limited Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
Figure CSL Limited Measles Vaccine Sales (K Sets) and Growth Rate (%) (2012-2017)
Figure CSL Limited Measles Vaccine Sales Market Share (%) in Europe (2012-2017)
Figure CSL Limited Measles Vaccine Revenue Market Share (%) in Europe (2012-2017)
Table Merck & Co. Basic Information List
Table Merck & Co. Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
Figure Merck & Co. Measles Vaccine Sales (K Sets) and Growth Rate (%) (2012-2017)
Figure Merck & Co. Measles Vaccine Sales Market Share (%) in Europe (2012-2017)
Figure Merck & Co. Measles Vaccine Revenue Market Share (%) in Europe (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
Figure Novartis AG Measles Vaccine Sales (K Sets) and Growth Rate (%) (2012-2017)
Figure Novartis AG Measles Vaccine Sales Market Share (%) in Europe (2012-2017)
Figure Novartis AG Measles Vaccine Revenue Market Share (%) in Europe (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
Figure Pfizer Measles Vaccine Sales (K Sets) and Growth Rate (%) (2012-2017)
Figure Pfizer Measles Vaccine Sales Market Share (%) in Europe (2012-2017)
Figure Pfizer Measles Vaccine Revenue Market Share (%) in Europe (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
Figure Sanofi Measles Vaccine Sales (K Sets) and Growth Rate (%) (2012-2017)
Figure Sanofi Measles Vaccine Sales Market Share (%) in Europe (2012-2017)
Figure Sanofi Measles Vaccine Revenue Market Share (%) in Europe (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Measles Vaccine
Figure Manufacturing Process Analysis of Measles Vaccine
Figure Measles Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Measles Vaccine Major Players in 2016
Table Major Buyers of Measles Vaccine
Table Distributors/Traders List
Figure Germany Measles Vaccine Sales (K Sets) and Growth Rate Forecast (2017-2022)
Figure Germany Measles Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure UK Measles Vaccine Sales (K Sets) and Growth Rate Forecast (2017-2022)
Figure UK Measles Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure France Measles Vaccine Sales (K Sets) and Growth Rate Forecast (2017-2022)
Figure France Measles Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Russia Measles Vaccine Sales (K Sets) and Growth Rate Forecast (2017-2022)
Figure Russia Measles Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Benelux Measles Vaccine Sales (K Sets) and Growth Rate Forecast (2017-2022)
Figure Benelux Measles Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Italy Measles Vaccine Sales (K Sets) and Growth Rate Forecast (2017-2022)
Figure Italy Measles Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Spain Measles Vaccine Sales (K Sets) and Growth Rate Forecast (2017-2022)
Figure Spain Measles Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Measles Vaccine Sales Forecast by Countries (2017-2022)
Figure Europe Measles Vaccine Sales (K Sets) Market Share (%) Forecast by Countries (2017-2022)
Figure Europe Measles Vaccine Sales Market Forecast by Countries in 2022
Table Europe Measles Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Measles Vaccine Revenue (Million USD) Market Share (%) Forecast by Countries (2017-2022)
Figure Europe Measles Vaccine Revenue (Million USD) Market Forecast by Countries in 2022
Table Europe Measles Vaccine (K Sets) Sales Forecast by Type (2017-2022)
Figure Europe Measles Vaccine Sales Market Share (%) Forecast by Type (2017-2022)
Figure Europe Measles Vaccine Sales Market Share (%) Forecast by Type in 2022
Table Europe Measles Vaccine (K Sets) Sales Forecast by Applications (2017-2022)
Figure Europe Measles Vaccine Sales Market Share (%) Forecast by Applications (2017-2022)
Figure Europe Measles Vaccine Sales Market Share (%) Forecast by Applications in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $3922
USD $4922
USD $7844

+1 (704) 266-3234

Have a Question?

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Trusted by The Best
    Over 400 of the Fortune 500 buy their research from us.
  • Why Us Customer Support
    24 / 7 phone and email support..
  • Why Us Safe & Secure
    Your payment details are protected by us.